| RWIBX | SMYSX | RWIBX / SMYSX | |
| Total Expense Ratio | 1.51 | 0.83 | 182% |
| Annual Report Gross Expense Ratio | 1.51 | 0.83 | 182% |
| Fund Existence | 24 years | 7 years | - |
| Gain YTD | 13.017 | 9.800 | 133% |
| Front Load | N/A | N/A | - |
| Min. Initial Investment | 250 | 1000000 | 0% |
| Min. Initial Investment IRA | N/A | N/A | - |
| Net Assets | 160B | 638M | 25,078% |
| Annual Yield % from dividends | 0.74 | 0.77 | 97% |
| Returns for 1 year | 17.83 | 21.31 | 84% |
| Returns for 3 years | 46.73 | 74.95 | 62% |
| Returns for 5 years | 27.84 | 56.53 | 49% |
| Returns for 10 years | 98.11 | N/A | - |
| 1 Day | |||
|---|---|---|---|
| MFs / NAME | Price $ | Chg $ | Chg % |
| BIPSX | 44.07 | N/A | N/A |
| ProFunds Biotechnology UltraSector Svc | |||
| TSVRX | 22.11 | N/A | N/A |
| PGIM Quant Solutions Small-Cap Val R | |||
| ACAYX | 66.15 | N/A | N/A |
| Alger Capital Appreciation Instl Y | |||
| FIJCX | 89.83 | N/A | N/A |
| Fidelity Advisor Consumer Staples Z | |||
| DFIEX | 22.01 | -0.42 | -1.87% |
| DFA International Core Equity 2 I | |||